Susan is Senior Vice President of Regulatory and Medical Affairs with overall responsibility for QA/Compliance, Technical Drug Development, Manufacturing and Logistics. Susan and her team are also responsible for post-marketing drug surveillance, drug safety and phase IV clinical studies. Since joining Alimera in March 2004, her team has filed three INDs, an NDA and Clinical Trial Applications in several countries (Canada, the EU and India).
Immediately prior to Alimera, Susan was the Vice President of Regulatory and Medical Affairs at Novartis Ophthalmics. She has twenty three years of ophthalmic regulatory experience having worked with Allergan, J&J, Alcon and Novartis. Her product development background is wide: drugs (human and animal), ophthalmic irrigating solutions, contact lenses and contact lens care, viscoelastics, intraocular lenses, ophthalmic surgical instruments and equipment - both US and international. Susan has been responsible for twelve NDA and several ANDA FDA approvals. Susan has a BS and Masters degrees in Chemistry.
